Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?

التفاصيل البيبلوغرافية
العنوان: Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?
المؤلفون: Shinya Minatoguchi, Nobuhiro Takasugi, Tomoki Kubota, Hiroaki Ushikoshi, Takuma Aoyama, Itta Kawamura, Takahiko Yamaki, Masanori Kawasaki, Shinichiro Tanaka, Genzou Takemura, Shinsuke Ojio, Shinji Yasuda, Munenori Okubo, Yoshiyuki Ishihara, Kazuhiko Nishigaki
المصدر: Journal of Cardiology. 52(1):39-48
بيانات النشر: Elsevier BV, 2008.
سنة النشر: 2008
مصطلحات موضوعية: Cardiac function curve, Male, medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, Angina pectoris, Lansoprazole, Diastole, Proton-pump inhibitor, Proton pump inhibitor, Coronary Angiography, 2-Pyridinylmethylsulfinylbenzimidazoles, Ventricular Function, Left, Internal medicine, medicine, Humans, Ventricular function, End-systolic volume, Aged, Aspirin, Ejection fraction, business.industry, Angiography, Percutaneous coronary intervention, Proton Pump Inhibitors, Stroke Volume, Middle Aged, Famotidine, H2-blocker, Histamine H2 Antagonists, Cardiology, Female, business, Cardiology and Cardiovascular Medicine, medicine.drug
الوصف: Aspirin and anti-platelet drugs are used commonly for patients with coronary heart disease. Proton pump inhibitor (PPI) and high-dose H2-blocker were recommended for preventing NSAIDs-related ulcer. Previously H2-blocker reported to have some negative cardiovascular effects. Additionally, a recent in vitro study showed that PPI reduced cardiac contractility. In this study, we evaluated whether chronic administration of PPI and high-dose H2-blocker affects left ventricular function.Fifty-two stable angina patients were enrolled and classified into PPI group ([P]; lansoprazole: 15 mg/day, n=28), H2-blocker group ([H]; famotidine: 40 mg/day, n=8), and control ([C]; none or mucosal-defense drug, n=16). Eligible patients showed normal cardiac function in initial catheterization without administrated PPI or H2-blocker. They received percutaneous coronary intervention and follow-up catheterization. We compared changes in ejection fraction (EF: %), end diastolic/systolic volume index (EDVI/ESVI: ml/m(2)), and peak positive/negative dp/dt (+/-dp/dt: mmHg/s) in left ventricular angiography series.There were no significant differences among three groups regarding patient characteristics, backgrounds of angiographic and intervention, except for fewer smokers in [C]. Other drugs such as beta- and Ca-blocker did not have effects on cardiac function except for aspirin during 255+/-115 days follow-up. Rate of EF changes significantly decreased in [P], and tended to decrease in [H] (C: 3.8+/-9.8%, H: -1.6+/-7.6%, P: -2.1+/-5.9%; p0.05 for [C] vs. [P]). Those of ESVI changes were significantly greater in [P], and tended to be greater in [H] (C: -4.5+/-16.2%, H: 4.9+/-15.5%, P: 7.3+/-16.2%; p0.05 for [C] vs. [P]), though, EDVI changes' were similar (C: 2.5+/-8.9%, H: 2.6+/-3.6%, P: 1.6+/-6.1%; p=ns). Rate of +/-dp/dt-changes tended to decrease in [H] (+dp/dt: C: 3.9+/-15.5%, H: -10.0+/-25.2%, P: 0.3+/-19.6%; p=ns, -dp/dt: C: -0.1+/-19.5%, H: -8.5+/-20.4%, P: 5.7+/-27.7%; p=ns).In this study, PPI and high-dose H2-blocker have EF-reducing tendency. However, these changes were small and these drugs seemed to exhibit little influence clinically.
تدمد: 0914-5087
DOI: 10.1016/j.jjcc.2008.05.004
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaeb9b497fd79cc3f5ef24331de3caaa
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....eaeb9b497fd79cc3f5ef24331de3caaa
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09145087
DOI:10.1016/j.jjcc.2008.05.004